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Assessment of the dielectrophoresis (DEP) cross-over frequency (fxo), cell diameter,
and derivative membrane capacitance (Cm) values for a group of undifferentiated
human embryonic stem cell (hESC) lines (H1, H9, RCM1, RH1), and for a
transgenic subclone of H1 (T8) revealed that hESC lines could not be discriminated
on their mean fxo and Cm values, the latter of which ranged from 14 to 20mF/m
2.
Differentiation of H1 and H9 to a mesenchymal stem cell-like phenotype resulted
in similar significant increases in mean Cm values to 41–49mF/m
2 in both lines
(p< 0.0001). BMP4-induced differentiation of RCM1 to a trophoblast cell-like
phenotype also resulted in a distinct and significant increase in mean Cm value to
28mF/m2 (p< 0.0001). The progressive transition to a higher membrane capacitance
was also evident after each passage of cell culture as H9 cells transitioned to a
mesenchymal stem cell-like state induced by growth on a substrate of hyaluronan.
These findings confirm the existence of distinctive parameters between
undifferentiated and differentiating cells on which future application of
dielectrophoresis in the context of hESC manufacturing can be based. VC 2012
American Institute of Physics. [http://dx.doi.org/10.1063/1.4771316]
I. INTRODUCTION
Human embryonic stem cells (hESCs) isolated from early blastocyst stage embryos1,2 and
comparably pluripotent stem cells induced from adult cells by gene transduction3 (iPSCs)
constitute a promising resource for disease modeling, drug screening, and cell therapies for re-
generative medicine. This is found on their immortality and pluripotency, as compared to the
restricted growth potential and repertoires of adult tissue-sourced stem cells. However, the
breadth of this capacity also makes controlling cell behavior in vitro more difficult, potentially
undermining their utility due to variable and heterogeneous cell production and the difficulty of
distinguishing cells of a desired phenotype from other contaminating populations. Thus, to
achieve standardized production of the quantity and type of cells desired for particular applica-
tions, there is a need for sensitive and non-invasive methods to discriminate and ultimately seg-
regate live cell populations.
Dielectrophoresis (DEP) is a well studied electrokinetic technique4–7 which has been
used to discriminate between distinct cellular identities in heterogeneous populations, notably
haematopoietic stem cells and differentiated derivatives in bone marrow and blood,8,9 mesen-
chymal stem cells in adipose tissue,10 and neural stem cell populations.11,12 A DEP device for
antibody-independent capture of viable circulating cancer cells in blood has already been
developed,13 and theoretically DEP could provide a simple and non-invasive way to
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positively or negatively select for target or contaminating cell types in a cell preparation
intended for transplantation. The DEP response of a cell involves either movement up a field
gradient towards an electrode (positive DEP) or down a field gradient away from an electrode
(negative DEP). A transition between these two responses occurs where the effective polaris-
ability of the cell matches that of the surrounding medium, and this can occur at both a low
frequency (kHz range) or high frequency (>100 MHz). In the kHz range explored in this
work, the corresponding DEP cross-over frequency fxo for a spherical cell of radius r is given








where Cm is the specific capacitance of the cell membrane and rm is the conductivity of the
suspending medium.7
Measurement of fxo and Cm has been shown to provide a sensitive, non-invasive way to
monitor changes in cell states associated with activation and clonal expansion, apoptosis, necro-
sis, and responses to chemical and physical agents.14–17 As such, DEP could be applied in the
context of stem cell processing as a means for real-time characterisation of the identity and via-
bility of manufactured cell preparations.
Recently, the application of DEP to neural stem cell populations suggested that the differ-
entiation fate of neural stem cells could be predicted by distinct changes in their fxo and Cm
values before the presence of specific cell-surface proteins (antigens) could be detected.12,13 In
the present study, our objective was to evaluate DEP as a means to discriminate and character-
ize undifferentiated hESCs and differentiating progeny. This is an important prerequisite to an
ambition to use DEP in the context of manufacturing hESC derived cell products given
variation which can exist between cell lines in the course of adaptation to culture or genetic
modification. Using the aforementioned Eq. (1), we measured fxo and derive Cm values in sev-
eral undifferentiated hESC lines (H1, H9, RCM1, RH1),1,18–20 a transgenic clonal derivative
(T8; a subclone of H1 expressing a genome-integrated green fluorescent protein (GFP) reporter
under the control of the OCT4-pluripotency associated transcription factor promoter),20 and
derivatives of these cell lines to multipotent-mesenchymal-stem cell like cells21 and to tropho-
blast.22 Our findings confirm the existence of distinctive parameters of undifferentiated and dif-
ferentiating cells on which future application of DEP in hESC manufacturing can be based.
II. MATERIALS AND METHODS
A. Cell culture
The use of hESC lines in this project was approved by the MRC steering committee over-
seeing the UK Stem Cell Bank. RCM1 and RH1 were derived at the Roslin Institute under a
license from the Human Fertilisation and Embryology Authority to P. De Sousa and licensed
from Roslin Cells and Geron, respectively. Both cell lines have been deposited in the UKSCB
(www.ukstemcellbank.org.uk). H1 and H9 were derived first at Wisconsin Regional Primate
Research Center, University of Wisconsin and licensed from WiCell. They are available from
the Wisconsin International Stem Cell Bank (www.wicell.org). The T8 cell line was derived at
the Roslin Institute by transfecting the H1 hESC cell line with an octamer-binding transcription
factor 4-GFP (OCT4-GFP) reporter.
RCM1,18 RH1,19 H1 and H9,1 and T8 (Ref. 20) hESCs were cultured on plastic tissue culture
plates (Corning Inc., NY) coated with growth factor-reduced MatrigelTM (Becton Dickinson) at
37 C, 5% CO2. T8 hESCs were cultured in mTeSR1 medium (Stemcell Technologies) supple-
mented with 100 lgml1 G418 (Gibco).20 RCM1, RH1, H1, and H9 hESCs were cultured in
mTeSR1 alone. Cells were routinely passaged using 200 units/ml of collagenase in Knockout Dul-
becco’s modified Eagle medium (KO-DMEM, Invitrogen) followed by manual scraping.
H1 and H9 hESCs were differentiated to a mesenchymal stem cell like phenotype using an
established protocol involving successive passaging on a substrate of hyaluronan (HA), also
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known as hyaluronic acid or hyaluronate,21 in a human dermal fibroblast conditioned medium
(HDF-CM) composed of KO-DMEM, 20% knockout serum replacement (KOSR, Invitrogen),
1mM glutamine, 0.1mM b-mercaptoethanol, and 4 ng/ml bFGF, prepared as described previ-
ously.17 Mesenchymal stem cell-like lines originating from H1 and H9 were designated H1-
MSC and H9-MSC, respectively. A stock solution of hyaluronan (1200 kD, Proud.385908,
Merck-Calbiochem, Nottingham, UK) was produced by solubilising it in physiological strength
phosphate buffered saline (PBS) at 10mg/ml and used for substrate coating. Tissue culture
wells were coated with HA stock solution applied at 0.1ml/cm2 for 30min at 4 C before
warming to room temperature and grown in 80% KO-DMEM and 20% KOSR (Gibco). For
trophoblast cell differentiation, RCM1 hESCs were cultured on MatrigelTM (Becton Dickinson)
coated plastic tissue culture plates in HDF-CM (Ref. 18) further supplemented with bone mor-
phogenetic protein (BMP4) at 100 ng/ml for 7 days as described previously.22 These cells were
designated RCM1-trophoblast.
For immunolabeling, both hESCs and differentiated cells were washed in PBS buffer and
fixed with 4% paraformaldehyde (PFA), permeabilised with 0.2% igepal (Sigma), and blocked
in 10% rabbit serum (Millipore). Fixed and permeabilised hESCs were incubated with mouse
anti-OCT4 (dilution 1:50, Santa Cruz Biotechnology). Primary antibody binding was detected
by incubating with rabbit anti-mouse Alexa-Fluor
VR
-488 (dilution 1:200, Invitrogen); nuclei
were counterstained with DAPI23 (Roche). Fixed and permeabilised HA-differentiated cells
were washed in PBS and stained to detect mesenchymal markers by incubating with goat anti-
human CD105 (1:50 dilution, R&D Systems), and mouse anti-human STRO-1 (1:200 dilution,
Millipore). Secondary antibodies were donkey anti-goat Alexa-Fluor-555 (1:400 dilution, Invi-
trogen), and rabbit anti-mouse Alexa-Fluor-488 (1:200 dilution, Invitrogen), respectively. Fixed
and permeabilised RCM1-trophoblast cells were washed in PBS and incubated with mouse anti-
human CDX2 (1:50 dilution, Vector labs) and mouse anti-hCG-b (1:25 dilution, Abcam). Pri-
mary antibodies were detected by incubating with goat anti-mouse Alexa-Fluor-488 (dilution
1:200, Invitrogen) and nuclei were counterstained with DAPI23 (Roche). Images were captured
with a Zeiss Observer microscope and Nikon camera.
B. Osteoblast formation
Osteogenic differentiation was induced as previously described by Sottile et al.24 An osteogenic
(OS) supplement consisting of 50lM ascorbic acid phosphate (Wako, Neuss, Germany), 10mM
b-glycerophosphate (Sigma-Aldrich, Dorset, UK), and 100nM dexamethasone (Sigma-Aldrich,
Dorset, UK) was added to DMEM medium. Cells grown previously on HA (H1) for 10 passages
were plated on 0.1% gelatin and treated with embryoid body differentiation (EBD) medium consist-
ing of 80% KO-DMEM (Invitrogen), 20% fetal bovine serum (FBS) (PAA Laboratories, Pasching,
Austria), 1mM L-glutamine, 0.1mM l-mercaptoethanol, 1% nonessential amino acids (all Invitro-
gen) þ/ OS that was changed every 2 days over the indicated intervals.
1. Mineralisation analysis
For mineralized nodule detection, fixed wells of cells were washed twice with calcium and
magnesium-free (CMF)-PBS before incubation with a 1% Alizarin-Red S (Sigma-Aldrich, Dor-
set, UK) solution in CMF-PBS for 10min. This was followed by washing twice with water and
then fixation in 95% methanol. Cell matrix-associated calcium deposition was determined in
96-well plates using the Sigma calcium assay kit (Sigma-Aldrich, Dorset, UK), in triplicate
wells.
C. Flow cytometry
Single cell suspensions of cultured cells were prepared by treatment with Trypsin-EDTA
(Gibco Invitrogen, Paisley, UK) for 5–10min at 37 C followed by re-suspension in FACS PBS
(PBS with 0.1% bovine serum albumin [BSA]). Cells were incubated for 20min at 4 C with
pre-conjugated MSC markers CD73-PE (BD Biosciences), CD105-FITC, CD90-FITC, Stro1-
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APC, CD34-PE (BD Biolegend), and CD14-PE (Becton Dickson). To remove unbound anti-
body, 2ml of FACS PBS were added per aliquot, and decanted after centrifugation at
(1300 rpm) for 5min. Cell samples finally resuspended in 250ll FACS PBS and analyzed using
a flow cytometer (FACSCalibur Becton Dickinson) equipped with 488 nm and 633 nm lasers
and standard filter set. FACS data were analyzed and plotted using FCS EXPRESS software.
D. DEP studies
DEP cross-over frequencies fxo for individual cells were obtained using the electrode design
shown in Figure 1. The electrodes were fabricated using standard photolithography and liftoff
techniques, and consisted of gold (150 nm) thermally evaporated onto a chrome adhesion layer
(5 nm) and patterned into an interdigitated array on a glass substrate. The electrode substrate
formed the floor of an open chamber, of internal length 10mm, width 10mm, and height 80lm,
constructed from polydimethylsiloxane (PDMS) bonded onto the glass substrate containing the
electrodes. The spatial variation of the field non-uniformity generated by this interdigitated elec-
trode design, characterized by the factor rE2, was modeled using COMSOL (Multiphysics 4.3) finite
element software. This information was used to derive the magnitude of the DEP force acting on
typical cells as a function of the applied sinusoidal voltage and location above the electrode plane.
FIG. 1. (Top): Interdigitated electrode geometry used to determine the DEP cross-over frequency fxo. (Bottom): COMSOL
Multiphysics simulation of the DEP force (log10[N]) acting on a 10lm diameter cell (Clausius-Mossotti factor¼ 0.5) with
an applied voltage of 3V (pk), as a function of distance (x lm) along and height above (z lm) the electrode plane.
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An example of this modelling is shown in Figure 1. The maximum Brownian diffusional force
(kT/2r) acting on a cell of radius 5lm at room temperature is 4 1016 N, and from Figure 1, the
corresponding DEP force for an applied voltage of 3V(pk) greatly exceeded this value. However,
the sedimentation force acting on a 5 lm radius cell can be estimated as 2 1013 N (assuming a
specific density difference of 40 kg/m3 between the medium and cell). To ensure that sedimenta-
tion forces did not influence the assessment of the DEP force when close to fxo, studies were lim-
ited to those cells located no higher than 20 lm above the electrode plane.
Before DEP characterization the cells were centrifuged (100 g, 5min) and washed twice
in 10ml of the DEP medium, before final suspension in this medium at a density of 107 cells/
ml. The DEP isotonic medium consisted of 8.5% (w/w) sucrose, 0.5% (w/w) glucose, at pH 7.4
(adjusted with NaOH) and conductivity 33 mS/m, adjusted with PBS. Osmolality (310 mOsm)
and conductivity values were measured using an osmometer (Advanced Instruments Inc., Model
3300) and a conductivity meter (Oakton CON 510), respectively. Cell suspensions were pipet-
ted onto the electrodes, the chamber was closed with a cover slip and then mounted in an
inverted microscope (Meiji TC5100). Sinusoidal voltages of 3V (pk) were applied to the elec-
trodes in continuous incremental steps of 10 kHz, commencing at 10 kHz and finishing at
200 kHz, using an Agilent/HP 3325A signal generator. By focusing on the electrode plane
discrimination between cells undergoing negative DEP and positive DEP was possible, and an
estimation of fxo was made for each cell by analysis of video images captured during this pro-
cedure. The diameter of each characterized cell was measured using Free Ruler (www.pascal.
com/software/freeruler).
E. Statistical analysis
Statistical analyses (unpaired t-tests or one-way ANOVA with Tukey’s post-hoc test, as
appropriate) were performed in GraphPad Prism, version 6.
III. RESULTS AND DISCUSSION
The undifferentiated phenotype and pluripotency of hESC lines used in this study has been
reported in previous studies.1,18–20 Flow cytometry confirmed all lines were positive for undif-
ferentiated glycolipids SSEA-4 and TRA-1-60, and negative for SSEA-1 (Table I). The former
were lower in the transgenic GFP reporter-expressing T8 line. By in situ immunocytochemistry
undifferentiated cell colonies in all lines were positive for pluripotency associated transcription
factors, Oct4 and Nanog (Oct4 shown for H1, Figure 2(a)). H1 and H9 hESC’s were differenti-
ated to MSC-like lineages as previously reported in Harkness et al.21 Consistent with an adult
tissue derived MSC flow cytometry confirmed cells were CD73þ, CD105þ, CD90þ, and
Stro1þ and CD14, CD34 (shown for H1, Figure 3). CD105 and Stro1 expression was con-
firmed by immunocytochemistry (Figure 2(b)). To confirm a MSC-like potency, cells were
induced to undergo mineralization in vitro in response to an osteogenic stimulus (OS) as previ-
ously described by Sottille et al.24 H1-MSC grown on HA for 10 passages underwent OS
TABLE I. Flow cytometry analysis data for five undifferentiated hESC lines used in the study confirmed that comparable
and high level of detection of SSEA-4 and TRA-1-60 and low levels of SSEA-1, as expected for this phenotype. Passage
number at which cells assessed denoted by “p.”
% marker positive
hESC lines SSEA-1 SSEA-4 TRA1-60
H1-p62 4 69 63
H9-p73 2 85 75
RCM1-p65 5 97 97
RH1-p53 5 60 71
T8-p98 3 32 66
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dependent mineralization characteristic of osteoblast-like cells. This was reflected by Alazarin
Red staining and calcium deposition (Figure 4), both of which increased over successive days
of stimulation and were maximal by 10 days of treatment respectively. RCM1 cells were non-
specifically differentiated to yield heterogeneous populations of trophoblast like cells using
another established protocol Xu et al.22 This was verified by immunostaining for CDX2 and
hCG-b markers (Figures 2(c) and 2(d)).
A summary of the experimentally measured cell diameters and DEP cross-over frequencies
(fxo) for the various hESCs and their differentiated progeny is given in Table II, together with
FIG. 2. Immunocytochemical confirmation of hESC and derivative lineages. Undifferentiated H1 hESCs (a) and MSC-like
cells (b), and RCM-1 trophoblast-like cells ((c), (d)) stained for OCT4 (a), MSC lineage markers CD105 (red) and Stro-1
(green) (b) and trophoblast markers CDX2 (green, (c)) and hCG-b (green, (d)). Nuclei are counterstained with DAPI (blue)
in all panels. Scale bar equals to 20 lm.
FIG. 3. Flow cytometric analysis of H1-MSC-like cells confirmed they were negative for CD14, CD34, and positive for
CD105 (64%), CD90 (40%), CD73 (99%), and Stro1 (58%).
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their membrane capacitances derived using Eq. (1). The standard deviation (r¼ 1) values given
are based on approximating the fxo and Cm distributions shown in Figure 5 as normal distribu-
tions. The results presented in Table II and Figure 5 indicate that there is a significant overlap
of the membrane capacitance values for the different hESC lines, with an overall mean value of
17.66 4.7mF/m2. The overlap of the fxo distributions shown in Figure 5(a) indicates that (apart
from with H9) it would not be possible to obtain pure samples of different hESC lines from a
mixed population using DEP as a separation tool. High purity separation of H9 cells from a
mixture of H1 and H9 cells, for example, could be obtained using the DEP device described by
Gupta et al.13 at 120 kHz with a cell medium conductivity of 35 mS/m, but with a recovery of
less than 50% for the H9 cells.
FIG. 4. Differentiation potential of hyaluronan-generated hES-derived MSC-like cells. (a) H1HA cells differentiate along
the ostoeogenic lineage to form mineralised bone when cultured in conditions conducive to osteogenesis (þOS) but not
control conditions (OS), as detected by alizarin red staining (red staining detectable from day 7 onwards). (b) Calcium
deposition quantified by Sigma calcium assay kit from the experiment in (a) shows that mineralised calcium only accumu-
lates to detectable levels in osteogenic conditions (þOS, black bars).
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From Figure 6, it is also clear that H1 and H9 cells both exhibited well-separated distribu-
tions of their fxo values, with little overlap, compared to those exhibited by their differentiated
progeny (H1-MSC and H9-MSC, respectively). Separation of pure populations of differentiated
cells from their progenitor H1 or H9 cells, with relatively high yields, should therefore be pos-
sible using DEP. However, DEP is unlikely to provide a sensitive method for distinguishing
populations of RCM1-trophoblast from RCM1 ES cells. Coupled with the distinct separation of
fxo distributions after differentiation, the results shown in Figures 6 and 7 indicate that there is
also a distinct increase of cellular membrane capacitance values (p< 0.0001). H1-MSCs and
TABLE II. Summary of the data (cell diameter, DEP cross-over frequency (fxo), and membrane capacitance (Cm)) obtained
for the human embryonic stem cells and their differentiated progeny.
Cell type Diameter (lm) fxo (kHz) Cm (mF/m
2)
H1 (n¼ 206) 14.56 2.8 68.46 16.2 16.16 3.9
H9 (n¼ 196) 11.16 1.7 101.66 25.8 14.26 3.7
RCM1 (n¼ 229) 14.26 2.3 68.26 22 17.66 6.7
RH1 (n¼ 254) 13.76 1.6 63.86 14.7 17.96 3.9
T8 (n¼ 134) 14.36 2.0 55.66 13.1 20.06 5.3
H1-MSC (n¼ 98) 15.06 3.1 26.16 7.4 41.66 11.0
H9-MSC (n¼ 185) 12.56 2.2 26.26 7.6 49.46 12.2
RCM1-trophoblast (n¼ 221) 12.86 1.6 44.46 11.8 28.36 7.3
FIG. 5. (a) Percentage distributions of the DEP cross-over frequencies (fxo) measured for the different human embryonic
stem cell lines. (b) The derived membrane capacitance (Cm) values.
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H9-MSCs exhibit a broad distribution of Cm values, extending from around 30 to 70mF/m
2,
compared to the more narrow ranges centered near 17 and 14mF/m2 exhibited by the H1 and
H9 cells, respectively. Although the RCM1 and RCM1-trophoblast exhibit a clear difference in
their mean Cm value (18mF/m2 and 28mF/m2, respectively), there is a significant overlap of
their Cm distributions. Finally, the changes in membrane capacitance and cell diameter for H9
cells as they are differentiated into H9-MSCs are shown in Figure 8 as a function of passage
number. There is no statistical difference in cell diameter between H9 and H9-MSCs at passage
2 and passage 3 (p> 0.05). However, there is a small but significant difference in diameter
when H9 cells are compared to H9-MSCs at passage numbers 4-9 (p< 0.05). Although the cell
size increases by 12.4% from H9 to H9-MSC (p9), the observed change in the cross-over fre-
quency can be primarily attributed to a significant increase in membrane capacitance of 247%
(p< 0.0001).
FIG. 6. Percentage distributions of the DEP cross-over frequencies (fxo) for (a) H1 and differentiated H1-MSC, (b) H9 and
H9-MSC, (c) RCM1 and RCM1-trophoblast.
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It is customary to employ the low-frequency (DC) approximation25 to analyse the dielectric
and conductive properties of a cell. For a spherical cell of radius r its effective permittivity eeff
is given by
eef f ¼ eoemrd /m ¼ rCm; (2)
where d is the membrane thickness, eo the permittivity of free space, em is the mean relative
permittivity of the material forming the membrane structure, and /m is the membrane-folding
factor to take into account cell surface features such as folds, microvilli, ruffles and blebs.26
For a perfectly smooth spherical cell /m¼ 1.
In the DEP literature,7,14,26 it is commonly assumed that different values of Cm for different
types of cell primarily reflect differences in the /m factor, and that the membrane thickness d
and relative permittivity em in Eq. (2) remain relatively fixed in value (5 nm, 2.0–2.2, respec-
tively26,27). However, recent DEP determination of Cm for fibroblasts and myoblasts, combined
FIG. 7. Membrane capacitance (Cm) values obtained for the human embryonic stem cells and their differentiated progeny.
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with Raman spectroscopic analyses of their membranes, has indicated that the chemical compo-
sition (e.g., proportion of saturated to unsaturated lipid content) may have a greater influence
on the values for d and em than previously thought.
28
Our study supports further development of DEP in the context of human embryonic stem
cell bioprocessing, in the course of expansion or directed differentiation for industrial or thera-
peutic applications. The most tractable application would be for purposes of real-time monitor-
ing of the representation of specific cell subpopulations through sampling limited quantities of
cells at the time of passaging. This would not require large numbers of cells and could be
implemented essentially using methods applied in this study. The application of DEP to the sep-
aration of relatively large numbers of cells (>50 000) has been previously demonstrated (e.g.,
Refs. 13 and 28). Scaled separation of tissue derived stem cells and differentiated progeny for
further culture by such approaches will require process parallelization.
IV. CONCLUSIONS
The various undifferentiated hESC lines (H1, H9, RCM1, RH1) and the transgenic clonal
derivative (T8) studied in this work could not be discriminated in terms of their DEP cross-
over frequencies and derived membrane capacitance values (14–20mF/m2). However, the dif-
ferentiated progeny (H1-MSC, H9-MSC, RCM1-trophoblast) could be discriminated from their
adult precursors (H1, H9, RCM1, respectively) by significant increases in their mean DEP
cross-over frequencies and derived membrane capacitance values. The mesenchymal stem cell-
like phenotypes (H1-MSC, H9-MSC) derived from differentiation of H1 and H9 exhibited
FIG. 8. The progression of (a) mean membrane capacitance Cm with 95% confidence interval bars, and (b) mean cell diam-
eter with 95% confidence interval error and passage number for the H9 cells cultured on an hyaluronan coated substrate.
(**** and *** signify a statistical difference with p< 0.0001 and p< 0.001 between groups).
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comparable Cm values of 41–49mF/m
2 (p< 0.0001), whereas induction of RCM1 to a tropho-
blast cell-like phenotype resulted in a smaller increase of mean Cm values from 17.6 to
28.3mF/m2 (p< 0.0001). Since different hESC lines were derived at different times in different
laboratories, and have been cultured in different conditions at different times, yet Cm and fxo
are similar, we conclude that a low membrane capacitance is a characteristic property of
hESCs. Furthermore, the result that Cm changes upon differentiation suggests that different phe-
notypes might be discriminated by their Cm values. The transition to a larger membrane capaci-
tance as the H9 cells differentiated to H9-MSCs was progressively evident after each passage
of the cell culture up to p9 (Figure 8). All of these findings confirm the existence of distinctive
parameters which differ between undifferentiated and differentiating hESCs, and suggests that
dielectrophoresis can be applied in the manufacturing process of these cells.
The increase in membrane capacitance during differentiation could arise from an increase
in the complexity of the membrane surface (appearance of folds, microvilli, blebs), or a com-
bined thinning and increase of the effective dielectric polarisability of the membrane struc-
ture.28 Which of these physico-chemical parameters contributes the most to the observed
changes of membrane capacitance remains a focus of our ongoing studies.
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